Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case report-Reference-Cited by-同舟云学术

Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case report

Published:2020-09-03 Issue:6 Volume:13 Page:1200-1204
ISSN:1865-7257
Container-title:Clinical Journal of Gastroenterology
language:en
Short-container-title:Clin J Gastroenterol

Author:

Arai Yoshinori^ORCID,Ogawa Maiko,Yamane Fumitsugu,Sumiyoshi Natsuki,Arimoto Rikako,Ando Yoshitaka,Endo Daisuke,Nakada Tatsuya,Sugawara Ichiro,Yokoyama Hiroshi,Shimoyama Keiko,Inomata Hiroko,Kawahara Yosuke,Kato Masayuki,Arihiro Seiji,Hokari Atsushi,Saruta Masayuki

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12328-020-01216-2.pdf

Reference16 articles.

1. Walsh A, Palmer R, Travis S. Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity. Gastrointest Endosc Clin N Am. 2014;24:367–78.

2. Langhorst J, Lauche R. It is about time: tailoring of an individualized multimodal treatment approach in ulcerative colitis. Digestion. 2014;89:139–41.

3. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365:1713–25.

4. Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390:2769–78.

5. Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med. 2015;372:1441–522.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tou Nong powder obstructs ulcerative colitis through the regulation of NF-κB/NLRP3/Caspase-1/GSDMD inflammasome pyroptotic pathway;Journal of Ethnopharmacology;2023-12

2. Significance of 5-Aminosalicylic Acid Intolerance in the Clinical Management of Ulcerative Colitis;Digestion;2022-11-10

3. Mesalazine;Reactions Weekly;2021-09

4. Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2021-01-27

5. Correction to: Mesalazine formulation intolerance due to suspected excipient allergy in the treatment of ulcerative colitis: a case report;Clinical Journal of Gastroenterology;2020-09-25